VIGL - Vigil Neuroscience GAAP EPS of -$0.57 in-line
2024-03-26 15:36:53 ET
More on Vigil Neuroscience
- Vigil Neuroscience appoints Kaufmann as Chief Medical Officer
- Vigil Neuroscience remains on track to report interim Phase 1 data for VG-3927 in healthy volunteers in mid-2024
- Seeking Alpha’s Quant Rating on Vigil Neuroscience
- Historical earnings data for Vigil Neuroscience
- Financial information for Vigil Neuroscience